🇺🇸 FDA

Company profile · Sponsor

InMed

InMed Pharmaceuticals

INM · NYSE pharma VANCOUVER, A1, USA
Pipeline
1
Drugs
0
Patents
8

Quick answer

InMed (INM) is a pharma company. headquartered in VANCOUVER, A1, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 8 patents to this profile..

Company facts

Ticker INM
Exchange NYSE
Company type pharma
Headquarters VANCOUVER, A1, USA
SEC CIK 0001728328

Pipeline (1)

Search pipeline →

  1. INM-755 (cannabinol) cream

    InMed

    Epidermolysis Bullosa Simplex

    phase 2 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12357604

    Topical formulations of cannabinoids and use thereof in the treatment of pain

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12083229

    Ocular drug delivery formulation

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12042479

    Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders

    Expires Mon Jul 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11471534

    Chitosan-pluronic complex and nano-carrier comprising same

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11472840

    Acetylcholine receptor-binding peptide

    Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8361485

    Conditioned cell culture medium compositions and methods of use

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8268336

    Compositions containing aromatic aldehydes and their use in treatments

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8246971

    Compositions containing aromatic aldehydes and their use in treatment

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is InMed?

InMed (INM) is a pharma company. headquartered in VANCOUVER, A1, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 8 patents to this profile..

What pipeline programs does InMed sponsor?

We track 1 ClinicalTrials.gov-linked program for InMed, including INM-755 (cannabinol) cream. Open each program for phase, modality, NCT IDs, and indication details.

Where does InMed company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.